ClinicalTrials.gg
RecruitingNCT07878624IVOMOCUpdated Oct 16, 2026

Vocal Biomarkers of Craving

An observational study in Addiction, sponsored by University of Bordeaux. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by University of Bordeaux · Observational

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.
Updated Oct 16, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

Addiction is a psychiatric disorder associated with craving, an unwanted, intense and persistent desire to use the substance/addictive behavior, leading to frequent relapses. Craving is fluctuating, influenced by internal factors or environmental context, and can be evaluated only by self-report which can be burdensome. It has been shown that craving predicts relapse, making it a major treatment target in addiction. Identify biomarkers of craving could enable to detect craving in a passive way (without major effort from individuals to report it) and would be a major improvement. The goal of this observational study is to explore if voice could be a biomarker of craving in adults with substance or behavioral addictions. The main question it aims to answer is:

  • Is there voice features associated with craving episodes in addiction ? Participants will undergo a cue-reactivity protocol with different voice tasks, and then answer Ecological Momentary Assessment (EMA) questionnaires on smartphone, with some of the questionnaires recorded out loud with the smartphone's microphone.
02

Conditions studied

  • Addiction

Browse trials for

Keywords

  • Addiction
  • Craving
  • Voice
  • Vocal features
  • Biomarker
03

In context

Behavior, Addictive

521 studies on the registry are indexed under Behavior, Addictive; 124 are open to participants now.

This study's planned enrollment of 120 is below the median of 158 across 106 observational studies indexed under Behavior, Addictive.

Browse Behavior, Addictive studies →

Lead sponsor

University of Bordeaux is the lead sponsor of 17 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be recruited from outpatient addiction treatment centers and the general population through social media, university and research websites, posters, and broader communication campaigns in the Bordeaux metropolitan area.

Eligibility criteria

Inclusion Criteria:

  • Identify at least one main problematic substance (cannabis, tobacco, alcohol, opiates, stimulant) or one main problematic addictive behavior (e.g : video games, gambling, food, sex…) as the primary addiction
  • PresentDiagnostic and Statistical Manual of Mental Disorders Fifth Edition () diagnosis for current Use Disorder for this primary addiction
  • Report regular craving and use of this primary addiction (more than 10 days in the last 30 days)
  • For participants recruited in treatment centers: receive outpatient treatment for this primary addiction
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Participants with DSM-5 diagnosis for a substance use disorder (SUD) or a behavioral addiction

    Adults meeting Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) criteria for diagnosis for a substance use disorder (SUD) /behavioral addiction, recruited to complete voice recordings during cue-reactivity protocol and during 14-28 days Ecological Momentary Assessment (EMA) protocol.

    Other: Cue reactivity paradigm · Other: Ecological momentary assessment

Interventions

  • OtherCue reactivity paradigm

    Single laboratory session during which participants undergo a cue-reactivity protocol and are exposed to neutral, addiction-cue, and stress-inducing conditions. Participants realize three different speech tasks (text reading, image description, response to semi-spontaneous question) recorded before and after the visualization of images, either neutral, addiction- related or stress-related. Craving and stress level are collected at different time during each block. No active treatment or intervention is administered.

  • OtherEcological momentary assessment

    Repeated ambulatory assessments: short smartphone questionnaires 4 times per day for 14-28 days to report craving, substance use/addictive behavior, and daily experiences, and self-initiated event-contingent reports of craving or substance use/addictive behavior. Some of the questionnaires have vocal items that should be directly answered by the participant speaking out loud. No intervention is provided.

06

What researchers measure

Primary outcomes

  1. Vocal acoustic features during the laboratory cue-reactivity protocol

    Comparison of acoustic parameters across conditions (neutral, addiction, versus stress conditions): fundamental frequency, pitch, formants, speech rate, articulation rate will be extracted from voice recordings collected during standardized text reading, image description, and semi-spontaneous speech tasks, using custom Python scripts.

    Time frame: Day 1 of individual participant timeline

  2. Vocal acoustic features during daily life

    Comparison of acoustic parameters in craving versus no-craving assessments: fundamental frequency, pitch, formants, speech rate, articulation rate will be extracted from voice recordings collected during semi-spontaneous speech elicited during EMA questionnaires, using custom Python scripts.

    Time frame: From day 2 through day 15 (up to day 29) of individual participant timeline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual participant data will be available upon reasonable request to the principal investigator. Access will be granted to researchers who provide a methodologically sound proposal for achieving the aims of the approved proposal. A data access agreement may be required before the data are released.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2025 (actual). Primary completion is estimated for Dec 2029, 50 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2026
First posted
Oct 16, 2026
StartActual
Oct 28, 2025
Primary completionEst.
Dec 2029
CompletionEst.
Apr 2030
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07878624
Lead sponsor
University of Bordeaux
Responsible party
Sponsor
First posted
Oct 16, 2026
Start date
Oct 28, 2025
Primary completion
Dec 2029 (estimated)
Completion
Apr 2030 (estimated)
Last update
Oct 16, 2026

Study contacts

Fuschia SERRE, Ph-D
Contact
fuschia.serre@u-bordeaux.fr
+33 05 56 56 17 38
Fuschia SERRE, Ph-D
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion